Examination of clinical improvement and postoperative complications preventive effect by Neurotropin as a preemptive analgegia for open carpal tunnel release

Examination of clinical improvement and postoperative complications preventive effect by Neurotropin as a preemptive analgegia for open carpal tunnel release - The efficacy of Noirotropin as a preemptive analgegia for open carpal tunnel release

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016328

Enrollment

Registered

2015-01-26

Start date

2012-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carpal tunnel syndrome

Interventions

Noirotropin and Vitamin B12 Vitamin B12

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with carpal tunnel syndrome

Exclusion criteria

Exclusion criteria: Patient with carpal tunnel syndrome which induced by trauma

Design outcomes

Primary

Measure	Time frame
VAS scale of pain and numbness, the Quick DASH and carpal tunnel syndrome severity score Japan Tegeka Society version severity score are used as a functional evaluation. We evaluate each patient on the first visit, preoperative, postoperative 1 month, 3 months, 6 months.	—

Countries

Japan

Contacts

Public ContactKenmoku Tomonori

Kitasato university school of medicine Orthopaedic surgery

pseudolefty811@yahoo.co.jp042-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026